Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)

Palomino Laboratories' (PALX) quarterly Total Liabilities came in at $336458.0 in Q4 2025, up 115.08% year-on-year from $156431.0 in Q4 2024, and down 66.32% quarter-over-quarter from $999013.0 in Q3 2025.

Palomino Laboratories (PALX) Total Liabilities (2022 - 2025) Analysis & Trends

Palomino Laboratories has disclosed Total Liabilities across 4 years of filings, most recently posting $336458.0 for Q4 2025.

  • Total Liabilities for Q4 2025 came in at $336458.0, up 115.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $336458.0 (up 115.08% YoY), and the FY2025 annual result was $336458.0, up 115.08% from the prior year.
  • Total Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $27804.0 in Q4 2022.
  • The 4-year median for Total Liabilities is $162925.0 (2024), against an average of $235268.4.
  • Peak annual rise in Total Liabilities reached 443.68% in 2024, while the deepest fall reached 40.14% in 2024.
  • Palomino Laboratories' Total Liabilities stood at $27804.0 in 2022, then surged by 301.46% to $111621.0 in 2023, then soared by 40.14% to $156431.0 in 2024, then jumped by 115.08% to $336458.0 in 2025.
  • The last three Total Liabilities figures came in at $336458.0 (Q4 2025), $999013.0 (Q3 2025), and $364431.0 (Q2 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 156,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Jun 30, 2023 35,804.00
Mar 31, 2023 31,554.00
Dec 31, 2022 27,804.00